(Q61908855)

English

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)

clinical trial

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

A Multicenter, Open-Label, Phase III Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP) (English)

0 references

medical condition

thrombocytopenia

0 references

start time

27 September 2016

0 references

end time

3 April 2018

0 references

number of participants

37

0 references

clinical trial phase

phase III clinical trial

0 references

research site

Pusan National University

0 references

Seoul National University

0 references

Samsung Medical Center

0 references

Yonsei University

0 references

research subject recruitment status

unknown

0 references

minimum age

19 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03164915

0 references

(Q61908855)

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)